Treatment of Non-Bullous Impetigo
For non-bullous impetigo with limited lesions, topical mupirocin 2% ointment applied three times daily for 5-7 days is the first-line treatment, but switch to oral antibiotics (dicloxacillin 250 mg four times daily or cephalexin 250-500 mg four times daily for adults) if lesions are extensive, involve multiple sites, or fail to respond after 3-5 days. 1, 2
Initial Assessment and Treatment Selection
When to Use Topical Therapy
- Topical mupirocin 2% ointment applied three times daily for 5-7 days is the preferred first-line treatment for localized impetigo 1, 2, 3
- Retapamulin applied twice daily for 5 days is an alternative topical option 1
- Topical therapy is preferred for limited disease due to fewer systemic side effects 2
- Do not use bacitracin or neomycin—they are considerably less effective and should not be used for impetigo treatment 4
When to Switch to Oral Antibiotics
You must use oral antibiotics in these situations:
- Extensive disease or numerous lesions 1, 4
- Lesions on the face, eyelid, or mouth 4
- No response to topical therapy after 3-5 days 4, 2
- Outbreaks affecting multiple people (to decrease transmission) 1
- Systemic symptoms present 4
- When topical therapy is impractical 2
Oral Antibiotic Regimens
For Presumed Methicillin-Susceptible S. aureus (MSSA)
Most S. aureus isolates from impetigo are methicillin-susceptible, making these your first-line oral options: 1
- Dicloxacillin 250 mg four times daily for adults (7-10 days) 1, 4, 2
- Cephalexin 250-500 mg four times daily for adults (7-10 days) 1, 4, 2
For Suspected or Confirmed MRSA
If MRSA is suspected or confirmed, use one of these agents: 1
- Clindamycin 300-450 mg three times daily for adults 1, 4, 2
- Trimethoprim-sulfamethoxazole 1-2 double-strength tablets twice daily for adults 1, 4
- Doxycycline (alternative option) 1
If Cultures Yield Streptococci Alone
- Oral penicillin is the recommended agent when only streptococci are isolated 1
- Critical pitfall: Penicillin alone is NOT effective for impetigo when S. aureus is present, as it lacks adequate staphylococcal coverage 4, 2
Culture Guidance
Gram stain and culture of pus or exudates are recommended to identify whether S. aureus and/or β-hemolytic Streptococcus is the cause, but treatment without these studies is reasonable in typical cases 1
When Cultures Are Strongly Recommended:
Duration of Therapy
Special Populations
Pediatric Patients
- Dicloxacillin: 12 mg/kg/day in 4 divided doses 2
- Avoid tetracyclines (doxycycline, minocycline) in children under 8 years 4, 2
- Topical mupirocin has demonstrated 78% clinical efficacy in pediatric patients aged 2 months to 15 years 3
Pregnant Patients
- Cephalexin is generally considered safe for pregnant patients 4, 2
- Avoid tetracyclines in pregnant women 4, 2
Penicillin-Allergic Patients
- Clindamycin is the preferred alternative for penicillin-allergic patients 4
Prevention of Spread
- Keep lesions covered with clean, dry bandages 4, 2
- Maintain good personal hygiene with regular handwashing 4
- Avoid sharing personal items that contact the skin 4
Monitoring and Follow-Up
- Re-evaluate if no improvement after 48-72 hours of therapy 2
- Consider alternative diagnosis if presentation is atypical or not responding to appropriate therapy 2
Special Circumstances: Poststreptococcal Glomerulonephritis Outbreaks
Systemic antimicrobials should be used for infections during outbreaks of poststreptococcal glomerulonephritis to help eliminate nephritogenic strains of Streptococcus pyogenes from the community 1